◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY
Home › All stocks › IMNN

Imunon, Inc. (IMNN) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-09

Imunon, Inc. (IMNN) operates in the Biotechnology industry and is headquartered in Lawrenceville, United States with about 20 employees. Its market capitalization is roughly $8 million. In the fiscal year ended 2025-12-31, IMNN reported $0M in revenue and ($14M) in net income.

Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States.

Interactive charts & full statements →

IMNN Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$0M$0M$0M$0M—
Operating Income (EBIT)($15M)($19M)($21M)($25M)—
Net Income($14M)($19M)($20M)($36M)—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IMNN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$0M$0M$0M$0M$0M—
Operating Income (EBIT)($4M)($4M)($4M)($3M)($4M)—
Net Income($4M)($4M)($3M)($3M)($4M)—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IMNN Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid$0M$0M———

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IMNN Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Dividends Paid—$0M————

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IMNN Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$12M$10M$22M$44M—
Total Liabilities$5M$6M$8M$15M—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IMNN viewer.

Other Companies in Biotechnology

← IMNMAll stocksIMPP →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.